Browse Category

Investment News News 23 December 2025

Commonwealth Bank of Australia Stock (ASX:CBA): Share Price Jumps on Refund Backflip as RBA Minutes Shift 2026 Rate Outlook

Commonwealth Bank of Australia Stock (ASX:CBA): Share Price Jumps on Refund Backflip as RBA Minutes Shift 2026 Rate Outlook

Commonwealth Bank of Australia (ASX:CBA) shares rallied on Tuesday, 23 December 2025, as investors weighed two storylines moving Australia’s largest bank stock right now: CommBank’s fresh commitment to “goodwill” payments tied to ASIC’s bank-fee review, and new Reserve Bank of
Boeing Stock After Hours: BA Holds Near $217 After Dec. 22, 2025 Close — Key News, Analyst Forecasts, and What to Watch Before Tuesday’s Open

Boeing Stock After Hours: BA Holds Near $217 After Dec. 22, 2025 Close — Key News, Analyst Forecasts, and What to Watch Before Tuesday’s Open

Boeing Company (The) stock (NYSE: BA) finished Monday’s session firmly higher, then turned choppy after the closing bell as investors digested a fresh mix of defense-and-space headlines, new contract flow, and the ongoing debate over Boeing’s 2026 cash-flow recovery story.
UnitedHealth Group (UNH) Stock After Hours Today (Dec. 22, 2025): Latest News, Analyst Forecasts, and What to Watch Before Tuesday’s Open

UnitedHealth Group (UNH) Stock After Hours Today (Dec. 22, 2025): Latest News, Analyst Forecasts, and What to Watch Before Tuesday’s Open

UnitedHealth Group Incorporated (NYSE: UNH) finished Monday’s session lower, even as the broader market pushed higher to start a holiday-shortened week. After the closing bell on December 22, 2025, trading in UNH was muted, suggesting investors largely stayed in “wait-and-see”
Amgen Stock After Hours (AMGN) on Dec. 22, 2025: FDA Clears New Prolia/Xgeva Biosimilars, Fitch Upgrades Credit — What to Know Before the Dec. 23 Open

Amgen Stock After Hours (AMGN) on Dec. 22, 2025: FDA Clears New Prolia/Xgeva Biosimilars, Fitch Upgrades Credit — What to Know Before the Dec. 23 Open

Amgen Inc. (NASDAQ: AMGN) ended Monday, December 22, 2025, modestly higher, but the more important story for Tuesday’s open is what hit after the closing bell: fresh FDA approvals for new denosumab biosimilars that reference Amgen’s blockbuster bone-drug franchises Prolia
Seagate Technology Holdings plc (STX) Stock After Hours on Dec. 22, 2025: Nasdaq‑100 Inclusion, Dividend Deadline, and What to Watch Before the Dec. 23 Market Open

Seagate Technology Holdings plc (STX) Stock After Hours on Dec. 22, 2025: Nasdaq‑100 Inclusion, Dividend Deadline, and What to Watch Before the Dec. 23 Market Open

Seagate Technology Holdings plc (NASDAQ: STX) ended Monday’s regular session sharply lower even as the broader market started the holiday week in positive territory—and investors are now turning their attention to three near-term catalysts: lingering Nasdaq‑100 reconstitution effects, a dividend
1 51 52 53 54 55 133
Go toTop